These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 22856590)

  • 1. Genome-wide profiling in melatonin-exposed human breast cancer cell lines identifies differentially methylated genes involved in the anticancer effect of melatonin.
    Lee SE; Kim SJ; Yoon HJ; Yu SY; Yang H; Jeong SI; Hwang SY; Park CS; Park YS
    J Pineal Res; 2013 Jan; 54(1):80-8. PubMed ID: 22856590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA and gene expression analysis of melatonin-exposed human breast cancer cell lines indicating involvement of the anticancer effect.
    Lee SE; Kim SJ; Youn JP; Hwang SY; Park CS; Park YS
    J Pineal Res; 2011 Oct; 51(3):345-52. PubMed ID: 21615491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential methylation hybridization profiling identifies involvement of STAT1-mediated pathways in breast cancer.
    Kim JH; Kang HS; Kim TW; Kim SJ
    Int J Oncol; 2011 Oct; 39(4):955-63. PubMed ID: 21674123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genistein inhibits DNA methylation and increases expression of tumor suppressor genes in human breast cancer cells.
    Xie Q; Bai Q; Zou LY; Zhang QY; Zhou Y; Chang H; Yi L; Zhu JD; Mi MT
    Genes Chromosomes Cancer; 2014 May; 53(5):422-31. PubMed ID: 24532317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells.
    Putnik M; Zhao C; Gustafsson JÅ; Dahlman-Wright K
    Biochem Biophys Res Commun; 2012 Sep; 426(1):26-32. PubMed ID: 22902638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.
    Sadikovic B; Andrews J; Rodenhiser DI
    Toxicol Appl Pharmacol; 2007 Dec; 225(3):300-9. PubMed ID: 17904174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining the effect of DNA methylation on gene expression in cancer cells.
    Lee CJ; Evans J; Kim K; Chae H; Kim S
    Methods Mol Biol; 2014; 1101():161-78. PubMed ID: 24233782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
    Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T
    Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
    Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical activity and breast cancer survival: an epigenetic link through reduced methylation of a tumor suppressor gene L3MBTL1.
    Zeng H; Irwin ML; Lu L; Risch H; Mayne S; Mu L; Deng Q; Scarampi L; Mitidieri M; Katsaros D; Yu H
    Breast Cancer Res Treat; 2012 May; 133(1):127-35. PubMed ID: 21837478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
    Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
    Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis.
    Faryna M; Konermann C; Aulmann S; Bermejo JL; Brugger M; Diederichs S; Rom J; Weichenhan D; Claus R; Rehli M; Schirmacher P; Sinn HP; Plass C; Gerhauser C
    FASEB J; 2012 Dec; 26(12):4937-50. PubMed ID: 22930747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway.
    Goeppert B; Konermann C; Schmidt CR; Bogatyrova O; Geiselhart L; Ernst C; Gu L; Becker N; Zucknick M; Mehrabi A; Hafezi M; Klauschen F; Stenzinger A; Warth A; Breuhahn K; Renner M; Weichert W; Schirmacher P; Plass C; Weichenhan D
    Hepatology; 2014 Feb; 59(2):544-54. PubMed ID: 24002901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clofarabine, a novel adenosine analogue, reactivates DNA methylation-silenced tumour suppressor genes and inhibits cell growth in breast cancer cells.
    Lubecka-Pietruszewska K; Kaufman-Szymczyk A; Stefanska B; Cebula-Obrzut B; Smolewski P; Fabianowska-Majewska K
    Eur J Pharmacol; 2014 Jan; 723():276-87. PubMed ID: 24296317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells.
    Heller G; Schmidt WM; Ziegler B; Holzer S; Müllauer L; Bilban M; Zielinski CC; Drach J; Zöchbauer-Müller S
    Cancer Res; 2008 Jan; 68(1):44-54. PubMed ID: 18172295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA demethylation by 5-aza-2-deoxycytidine treatment abrogates 17 beta-estradiol-induced cell growth and restores expression of DNA repair genes in human breast cancer cells.
    Singh KP; Treas J; Tyagi T; Gao W
    Cancer Lett; 2012 Mar; 316(1):62-9. PubMed ID: 22082530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
    Zhong S; Fields CR; Su N; Pan YX; Robertson KD
    Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
    Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
    Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.